A Phase 1, Open-label Safety Study of NKA in Patients With Type 2 Diabetes

Summary

The purpose of this study is to determine if selected renal cells, obtained by biopsy from a patient with chronic kidney disease (CKD) and Type 2 Diabetes (i.e., autologous cells) can be safely implanted back into the patient.

Timeline

Start

2013-12

Primary completion

2014-12

Completion

2014-12

Outcome

Outcome not reported

Stopped (Business): “Lack of funding”

Drugs

Indications